Arkolith/Insider Trading/AKTX/Form 4

Gaslightwala Abizer

President & CEO, DirectorAkari Therapeutics Plc (AKTX) · full profile →Form 4 · filed Jun 25, 2025
Net Buying
Open-Market Buys
$7K
Open-Market Sells
$0
Net Open-Market Flow
$7K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2025Buy(P)5K$1.16$6K278K
Jun 23, 2025Buy(P)943$1.15$1K272K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-089976) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML